Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney and bladder cancer, today ...

The study found that Focal One's treatment methods match up with the gold star standard of surgery, and improve quality of life outcomes.

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ ...

The procedure involves implanting electrodes to pinpoint seizure origins, stimulating them for confirmation, and then ablating the faulty brain area. This 'popping' sensation technique has helped ...

AngioDynamics, Inc. ANGO, yesterday, announced the receipt of the FDA’s 510(k) clearance for the NanoKnife System for prostate tissue ablation. The clearance for the NanoKnife System for ...

The study evaluated the safety and effectiveness of the system for ablating prostate tissue in patients with intermediate-risk prostate cancer (PCa). Conducted in collaboration with the Society of ...

The clearance is supported by data from the PRESERVE trial (NCT04972097), which evaluated the safety and effectiveness of the NanoKnife System in ablating prostate tissue in patients with intermediate ...

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews. This work is a continuation of a previous paper from the Arnold ...

The companies are now incorporating mapping technology into the ablating catheter to further streamline the procedure. And Tarakji said Medtronic is in early feasibility studies to study whether ...

Dr. Robert Ward prepares part of the FARAPULSE Pulsed Field Ablation System for a pulsed field ablation procedure to treat a patient with atrial fibrillation at Mayo Clinic Hospital, Saint Marys ...